Sentinel Spectrum is a drug owned by INTERVET, INC. It is protected by 4 US drug patents filed from 2015 to 2024. All patents have expired. Details of Sentinel Spectrum’s patents and their expiration are given below.
Exclusivity Information
Sentinel Spectrum holds 1 exclusivity out of which 1 has expired. Details of Sentinel Spectrum's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Sep 28, 2020 |
About Sentinel Spectrum
Sentinel Spectrum is a drug
owned by INTERVET, INC.
Sentinel Spectrum uses
Lufenuron, Milbemycin Oxime, Praziquantel as the active
ingredients.
Active Ingredient:
Sentinel Spectrum uses
Lufenuron,
Milbemycin Oxime, Praziquantel
as the active ingredients.
Check out other Drugs and Companies using
Lufenuron, Milbemycin Oxime, Praziquantel ingredient.